Clinical Trials Directory

Trials / Completed

CompletedNCT03449875

Global Post-market Registry for the Treovance Stent-graft.

A Post-Market Surveillance Clinical Registry of the TREOVANCE® Stent-Graft for Patients With Infrarenal Abdominal Aortic Aneurysms

Status
Completed
Phase
Study type
Observational
Enrollment
202 (actual)
Sponsor
Bolton Medical · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Patients with abdominal aortic aneurysms (AAA) suitable for endovascular aortic repair (EVAR) with Treovance were eligible to participate. Main inclusion criteria were: age 18-85 years; infrarenal AAA without significant infrarenal or distal iliac landing neck calcification or thrombus formation; infrarenal or distal iliac landing neck size requirements specified in the instructions for use. Main exclusion criteria: dissection/ruptured aneurysm or prior AAA endovascular or surgical repair. The primary endpoints were standard EVAR criteria.

Detailed description

The goal of the registry was to collect clinical data of TREOVANCE® device in subjects with infrarenal aortic aneurysms, specifically to evaluate if the diseased pathology is treated with an acceptable technical success rate, an acceptable complication rate and that the device performs as expected. The following endovascular measures/parameters were assessed for preliminary performance at the follow-up intervals: delivery/deployment, stent-graft migration, stent-graft patency, stent-graft integrity, endoleak, aneurysm sac size changes, limb ischemia, and vascular access complications. This registry was a prospective, multi-center, post-market non-randomized study. The goal was to gather safety and performance data on the device. Subjects diagnosed with infrarenal aortic aneurysms enrolled into the registry were treated with the TREOVANCE® Stent-Graft with Navitel® Delivery System. Pre-procedure baseline data was gathered as well as post-procedure assessments prior to hospital discharge and 1, 6, and 12 months post-implantation.

Conditions

Interventions

TypeNameDescription
DEVICETREOVANCE® Stent-Graft with Navitel® Delivery SystemEndovascular repair of abdominal aortic aneurysms.

Timeline

Start date
2014-02-05
Primary completion
2017-04-11
Completion
2017-04-11
First posted
2018-02-28
Last updated
2020-06-26

Locations

32 sites across 17 countries: Chile, Denmark, Germany, Greece, Hong Kong, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Spain, Sweden, Thailand, United Kingdom, Venezuela, Vietnam

Source: ClinicalTrials.gov record NCT03449875. Inclusion in this directory is not an endorsement.